Neurosoft Bioelectronics

# Neurosoft Bioelectronics **Entity class:** Concept or analytic term **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] ## Definition **Neurosoft Bioelectronics** is a concept or analytic term. [[wiki/Science Corporation|Science Corporation]] partnered with **Neurosoft Bioelectronics**. Multiyear, multimillion-dollar Science Ecosystem agreement announced Feb 20 2026. Neurosoft Bioelectronics develops [[wiki/ultra-soft flexible neural probes|ultra-soft flexible neural probes]]. Company aims at full cortical coverage and neural-data generation. Neurosoft Bioelectronics uses [[wiki/Science Ecosystem clinical-grade neural engineering stack|Science Ecosystem clinical-grade neural engineering stack]]. The entry centers on the concept's meaning, practical use, and boundaries, together with the examples that make the distinction operational rather than merely verbal. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Key Relationships - [[wiki/Science Corporation|Science Corporation]] partnered with **Neurosoft Bioelectronics**. Multiyear, multimillion-dollar Science Ecosystem agreement announced Feb 20 2026. - **Neurosoft Bioelectronics** is associated with [[wiki/foundation AI model of the brain|foundation AI model of the brain]]. ### Technology and research relationships - **Neurosoft Bioelectronics** develops [[wiki/ultra-soft flexible neural probes|ultra-soft flexible neural probes]]. Company aims at full cortical coverage and neural-data generation. - **Neurosoft Bioelectronics** uses [[wiki/Science Ecosystem clinical-grade neural engineering stack|Science Ecosystem clinical-grade neural engineering stack]]. ### People and institutional relationships - [[wiki/Nicolas Vachicouras|Nicolas Vachicouras]] is associated with **Neurosoft Bioelectronics**.  ## Research Edges  #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 761 — `develops` → [[wiki/ultra-soft flexible neural probes|ultra-soft flexible neural probes]]** — **VERIFIED_COMPANY_RELATIONSHIP**; evidence `SCIENCE_NEUROSOFT`. Company aims at full cortical coverage and neural-data generation. - **Edge 762 — `uses` → [[wiki/Science Ecosystem clinical-grade neural engineering stack|Science Ecosystem clinical-grade neural engineering stack]]** — **VERIFIED_COMPANY_RELATIONSHIP**; evidence `SCIENCE_NEUROSOFT`. - **Edge 763 — `trains` → [[wiki/foundation AI model of the brain|foundation AI model of the brain]]** — **VERIFIED_COMPANY_RELATIONSHIP**; evidence `SCIENCE_NEUROSOFT`. Company-stated objective; preserve as company claim. #### Incoming typed edges - **Edge 760 — [[wiki/Science Corporation|Science Corporation]] `partnered_with` → this entry** — **VERIFIED_COMPANY_RELATIONSHIP**; evidence `SCIENCE_NEUROSOFT`. Multiyear, multimillion-dollar Science Ecosystem agreement announced Feb 20 2026. - **Edge 767 — [[wiki/Nicolas Vachicouras|Nicolas Vachicouras]] `CEO_and_cofounder_of` → this entry** — **VERIFIED_COMPANY_RELATIONSHIP**; evidence `SCIENCE_NEUROSOFT`.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0059 — Strongly indicated.** Building a patient registry before a pivotal trial is an assertion that enrollment, not evidence, is the binding constraint. Registries are also longitudinal cohorts, and a longitudinal cohort of interfaced humans is the substrate on which every population-level claim about neural data will eventually rest. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0063 — Strongly indicated.** ADAPT-PD evaluated adaptive stimulation in clinical *and home* settings across 68 patients over a year, which means the dataset includes unsupervised daily life. Continuous neural telemetry outside the clinic is the precondition for every longitudinal model of a person's neural state. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0064 — Analytic.** Cutting initial programming time by 85% through automated electrode selection moves clinical judgment into an algorithm. Each such move raises the fraction of the therapy defined by the manufacturer's model rather than by the attending physician, which is a governance shift dressed as a workflow improvement. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0066 — Plausible.** Electrical modulation of autonomic pathways lets a device set inflammatory, metabolic, and cardiac setpoints continuously. That is real-time regulation of body systems by an implanted controller, and it arrives under ordinary disease indications rather than as enhancement. - **Canonical cluster:** [[wiki/Distributed Biological Interfaces|Distributed Biological Interfaces]] - **INF-0305 — Established.** Stimulating the vagus modulates systemic inflammatory signaling through a defined neural reflex, which means an electrical device can set an immunological parameter. Electricity substituting for a drug is the founding demonstration of bioelectronic medicine, and its indications expand annually. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0306 — Strongly indicated.** A stimulation parameter can be changed instantly and reversibly, while a pharmaceutical dose cannot be recalled once administered. Reversibility gives electrical therapeutics a control-theoretic advantage that will move indications from drugs to devices wherever a nerve carries the signal. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0372 — Established.** Ingestible sensors that confirm a pill was swallowed make adherence an observed variable rather than a reported one. Observation changes the relationship between patient and prescriber, and it is the first instance of compliance being technically enforced from inside the body. - **Canonical cluster:** [[wiki/Networked Body|Networked Body]]